JP2024516712A5 - - Google Patents

Info

Publication number
JP2024516712A5
JP2024516712A5 JP2023568213A JP2023568213A JP2024516712A5 JP 2024516712 A5 JP2024516712 A5 JP 2024516712A5 JP 2023568213 A JP2023568213 A JP 2023568213A JP 2023568213 A JP2023568213 A JP 2023568213A JP 2024516712 A5 JP2024516712 A5 JP 2024516712A5
Authority
JP
Japan
Prior art keywords
pheophorbide
pharmaceutical composition
analog
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568213A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516712A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050697 external-priority patent/WO2022232930A1/en
Publication of JP2024516712A publication Critical patent/JP2024516712A/ja
Publication of JP2024516712A5 publication Critical patent/JP2024516712A5/ja
Pending legal-status Critical Current

Links

JP2023568213A 2021-05-05 2022-05-04 ＳＡＲＳ－ＣｏＶ－２感染症の治療のためのクロロフィル誘導体の使用 Pending JP2024516712A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163201568P 2021-05-05 2021-05-05
US63/201,568 2021-05-05
PCT/CA2022/050697 WO2022232930A1 (en) 2021-05-05 2022-05-04 Use of chlorophyll derivatives for the treatment of sars-cov-2 infection

Publications (2)

Publication Number Publication Date
JP2024516712A JP2024516712A (ja) 2024-04-16
JP2024516712A5 true JP2024516712A5 (https=) 2025-05-12

Family

ID=83931896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568213A Pending JP2024516712A (ja) 2021-05-05 2022-05-04 ＳＡＲＳ－ＣｏＶ－２感染症の治療のためのクロロフィル誘導体の使用

Country Status (5)

Country Link
US (1) US20240366564A1 (https=)
EP (1) EP4333839A4 (https=)
JP (1) JP2024516712A (https=)
CA (1) CA3215826A1 (https=)
WO (1) WO2022232930A1 (https=)

Similar Documents

Publication Publication Date Title
JP2505944B2 (ja) （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
JP2022058688A5 (https=)
RU2007104095A (ru) Применение твердой пероральной дозировочной композиции пролонгированного действия для приготовления лекарственных средств
JP2023522010A5 (https=)
JP2023535744A5 (https=)
JP2023520323A5 (https=)
JP2016147914A (ja) 上気道の疾患およびインフルエンザ症候群を治療するための組成物
CL2024003601A1 (es) Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
JP2023545372A5 (https=)
JP2005508963A5 (https=)
ES2390226T3 (es) Tratamiento de enfermedades infecciosas
JP2022553888A5 (https=)
EA039000B1 (ru) Композиция с противовирусным эффектом
JP2024516712A5 (https=)
JP2023517130A5 (ja) Ａｚｄ１６５６又はその薬学的に許容される塩を含む、コロナウイルスによって引き起こされた肺炎及び／又は心筋炎の治療用組成物
BR112023002778A2 (pt) Ácido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il) carbamoil) ciclopentano-1-carboxílico e derivados do mesmo para uso no tratamento de doenças das vias aéreas
JP2024543259A5 (https=)
US11497747B2 (en) Compositions and methods for treating lung injuries associated with SARS-CoV-2 infections
JP2024531799A5 (https=)
IL110780A (en) Pharmaceuticals containing 1,3-bite (2-carboxy-chromone-5-ilexy) -propane for the treatment of colds
JP2023539847A5 (https=)
CN115884770A (zh) 治疗冠状病毒感染的联用药物及治疗方法
CN100364975C (zh) 一种抗呼吸道病毒的药物及用途
RU2538433C1 (ru) Фармацевтическая композиция для профилактики и лечения инфекционно-воспалительных заболеваний различной этиологии путем оромукозного введения
KR20090046746A (ko) 만성 폐쇄성 폐 질환을 치료하기 위한 에르도스테인 및 베타-2 작용제의 조합물